Literature DB >> 13689170

An assessment of the value of serum cholinesterase as a liver function test and in the diagnosis of jaundice.

W BURNETT.   

Abstract

This report assesses the value of cholinesterase (ChE) activity as an indicator of liver function and analyses its usefulness in the diagnosis of jaundice. A rapid method of determination has been used, and alterations in ChE activity in conditions other than liver disease have been studied to permit a fuller and more accurate survey of its value as a liver function test. The level of serum cholinesterase activity remains constant under normal circumstances, and follows the pattern of protein metabolism, falling in catabolism and rising in anabolism.In hepatocellular disease cholinesterase activity is lowered. Very low levels in cirrhosis with jaundice indicate a grave prognosis. Normal levels are usual in post-hepatic jaundice unless complicating factors are present, such as cholangitis or liver metastases. Serum cholinesterase is useful both as a liver function test and in the diagnosis of jaundice provided consideration is given to the other factors which affect the level of activity of the enzyme.

Entities:  

Keywords:  CHOLINESTERASE/blood; JAUNDICE/diagnosis; LIVER FUNCTION TESTS

Mesh:

Substances:

Year:  1960        PMID: 13689170      PMCID: PMC1413232          DOI: 10.1136/gut.1.4.294

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Studies of cholinesterase activity. III. Serum cholinesterase in obstructive jaundice and neoplastic disease.

Authors:  H M WILLIAMS; R V LAMOTTA; H J WETSTONE
Journal:  Gastroenterology       Date:  1957-07       Impact factor: 22.682

2.  Serum cholinesterase in hepatic and neoplastic diseases: a preliminary report.

Authors:  D W MOLANDER; M M FRIEDMAN; J S LADUE
Journal:  Ann Intern Med       Date:  1954-12       Impact factor: 25.391

3.  Serum acetylcholinesterase; its close correlation with serum albumin, and its limited usefulness as a test of liver function.

Authors:  K FREMONT-SMITH; W VOLWILER; P A WOOD
Journal:  J Lab Clin Med       Date:  1952-11

4.  Serum cholinesterase in health and disease.

Authors:  L J VORHAUS; R M KARK
Journal:  Am J Med       Date:  1953-06       Impact factor: 4.965

5.  Plasma cholinesterase activity in liver disease: its value as a diagnostic test of liver function compared with flocculation tests and plasma protein determinations.

Authors:  A WILSON; R J CALVERT; H GEOGHEGAN
Journal:  J Clin Invest       Date:  1952-05       Impact factor: 14.808

6.  Serum cholinesterase activity in the normal individual and in people with liver disease.

Authors:  K KAUFMAN
Journal:  Ann Intern Med       Date:  1954-09       Impact factor: 25.391

7.  Blood cholinesterase levels and range of personal variation in a healthy adult population.

Authors:  S CALLAWAY; D R DAVIES; J P RUTLAND
Journal:  Br Med J       Date:  1951-10-06

8.  Serum cholinesterase activity in liver disease.

Authors:  J D MANN; W I MANDEL; P L EICHMAN; M A KNOWLTON; V M SBOROV
Journal:  J Lab Clin Med       Date:  1952-04

9.  Determination of cholinesterase activity in human blood.

Authors:  W N ALDRIDGE; D R DAVIES
Journal:  Br Med J       Date:  1952-05-03

10.  Serum cholinesterase determination in the differential diagnosis of jaundice.

Authors:  J M O ALCALDE
Journal:  J Lab Clin Med       Date:  1950-09
View more
  7 in total

1.  Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.

Authors:  Rui Chen; Yexiong Tan; Min Wang; Fangjun Wang; Zhenzhen Yao; Liwei Dong; Mingliang Ye; Hongyang Wang; Hanfa Zou
Journal:  Mol Cell Proteomics       Date:  2011-04-07       Impact factor: 5.911

2.  The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers.

Authors:  Tanasorn Tunsaringkarn; Kalaya Zapuang; Anusorn Rungsiyothin
Journal:  Indian J Clin Biochem       Date:  2013-04-03

3.  Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

Authors:  Takayoshi Suga; Ken Sato; Yuichi Yamazaki; Tatsuya Ohyama; Norio Horiguchi; Satoru Kakizaki; Motoyasu Kusano; Masanobu Yamada
Journal:  World J Clin Cases       Date:  2015-12-16       Impact factor: 1.337

4.  Readthrough acetylcholinesterase is increased in human liver cirrhosis.

Authors:  María-Salud García-Ayllón; Cristina Millán; Carol Serra-Basante; Ramón Bataller; Javier Sáez-Valero
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Inhibitory effects of sodium arsenite and acacia honey on acetylcholinesterase in rats.

Authors:  Aliyu Muhammad; Oyeronke A Odunola; Michael A Gbadegesin; Abdullahi B Sallau; Uche S Ndidi; Mohammed A Ibrahim
Journal:  Int J Alzheimers Dis       Date:  2015-03-02

6.  Reduced serum butyrylcholinesterase activity indicates severe systemic inflammation in critically ill patients.

Authors:  Aleksandar R Zivkovic; Karsten Schmidt; Annette Sigl; Sebastian O Decker; Thorsten Brenner; Stefan Hofer
Journal:  Mediators Inflamm       Date:  2015-02-11       Impact factor: 4.711

7.  Ameliorative Effects of Honey, Propolis, Pollen, and Royal Jelly Mixture against Chronic Toxicity of Sumithion Insecticide in White Albino Rats.

Authors:  Atef M K Nassar; Yehia M M Salim; Khalid S A Eid; Hazem M Shaheen; Abdullah A Saati; Helal F Hetta; Amr Elmistekawy; Gaber El-Saber Batiha
Journal:  Molecules       Date:  2020-06-05       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.